SpringWorks is a commercial-stage biopharmaceutical company applying a precision medicine approach to developing and delivering life-changing medicines for people with severe rare diseases and cancer.
Founded in 2017, SpringWorks has a diversified targeted oncology pipeline spanning solid tumors and hematological cancers, including clinical trials in rare tumor types and highly prevalent, genetically defined cancers.
Industry
Biotechnology Research, Scientific Research and Development Services, Services
HQ Location
100 Washington Blvd
Stamford, Connecticut 06902, US
Keywords
lead productestrogen receptorselective estrogentumor characterizedlead product candidatesinhibition combination therapy